MB
Maxwell Bikoff
OtherActivePrincipal at Longitude Capital
56
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Maxwell Bikoff.
Investment Thesis & Strategy
Longitude Capital invests in various stages of biotech, consumer health, healthcare, health & hospital services, and health IT companies, seeking to partner with innovative teams developing transformative solutions.
Portfolio Companies
Selected investments from their portfolio of 56 companies
A
Aimmune Therapeutics
Other · , 0
8
89bio
Other · , 0
W
Whitehill Technologies
Other · , 0
E
Endeavor BioMedicines
Other · , 0
E
Encore Dermatology
Other · , 0
K
Kala Pharmaceuticals
Other · , 0
M
MURJ
Other · , 0
A
AqueSys
Other · , 0
I
Inozyme
Other · , 0
P
PixelOptics
Other · , 0
V
Vera Therapeutics
Other · , 0
C
Checkmate Pharmaceuticals
Other · , 0
Frequently Asked Questions
Maxwell Bikoff focuses on Seed stage investments.
Related Investors
Trevor Oelschig
San Francisco Bay Area, United States · 95 deals
Drew Harman
San Francisco Bay Area, United States · 94 deals
Ben Fletcher
San Francisco Bay Area, United States · 93 deals
Reva Nohria
San Francisco Bay Area, United States · 93 deals
Rajesh Swaminathan
San Francisco Bay Area, United States · 92 deals
Woody Marshall
San Francisco Bay Area, United States · 92 deals